Carbenoxolone inhibits TRPV4 channel‐initiated oxidative urothelial injury and ameliorates cyclophosphamide‐induced bladder dysfunction

Carbenoxolone (CBX) is a clinically prescribed drug for the treatment of digestive ulcer and inflammation. It is also a widely used pharmacological inhibitor of several channels in basic research. Given that the overactivity of several channels, including those inhibitable by CBX, underlies bladder...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cell Mol Med
Main Authors: Zhang, Xiling, Gao, Shan, Tanaka, Masayoshi, Zhang, Zhen, Huang, Yanru, Mitsui, Takahiko, Kamiyama, Manabu, Koizumi, Schuichi, Fan, Jianglin, Takeda, Masayuki, Yao, Jian
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5571544/
https://ncbi.nlm.nih.gov/pubmed/28244642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados